| Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis:[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee of the American … TF Scott, EM Frohman, J De Seze, GS Gronseth, BG Weinshenker Neurology 77 (24), 2128-2134, 2011 | 228 | 2011 |
| Neurosarcoidosis: progress and clinical aspects TF Scott Neurology 43 (1_part_1), 8-8, 1993 | 198 | 1993 |
| Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients TF Scott, K Yandora, A Valeri, C Chieffe, C Schramke Archives of neurology 64 (5), 691-696, 2007 | 187 | 2007 |
| Transverse myelitis: comparison with spinal cord presentations of multiple sclerosis TF Scott, K Bhagavatula, PJ Snyder, C Chieffe Neurology 50 (2), 429-433, 1998 | 131 | 1998 |
| MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group CHAMPS Study Group* Neurology 59 (7), 998-1005, 2002 | 120 | 2002 |
| Spinal cord neurosarcoidosis M Sohn, K Nozaki, DA Culver, MA Judson, TF Scott, J Tavee The American Journal of the Medical Sciences 347 (3), 195-198, 2014 | 104 | 2014 |
| Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma EJ Gettings, CT Hackett, TF Scott Multiple Sclerosis Journal 21 (5), 670, 2015 | 99 | 2015 |
| Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing β-interferon therapy MK Singh, TF Scott, WA LaFramboise, FZ Hu, JC Post, GD Ehrlich Journal of the neurological sciences 258 (1-2), 52-59, 2007 | 99 | 2007 |
| Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS JA Cohen, PB Imrey, PA Calabresi, KR Edwards, T Eickenhorst, ... Neurology 72 (6), 535-541, 2009 | 95 | 2009 |
| Neuromyelitis optica IgG status in acute partial transverse myelitis TF Scott, SL Kassab, SJ Pittock Archives of neurology 63 (10), 1398-1400, 2006 | 90 | 2006 |
| Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis TF Scott, SL Kassab, S Singh Multiple Sclerosis Journal 11 (4), 373-377, 2005 | 88 | 2005 |
| Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale TF Scott, P Nussbaum, H McConnell, P Brill Neurological research 17 (6), 421-422, 1995 | 87 | 1995 |
| Midline cerebral malformations and schizophrenia. TF Scott, TR Price, MS George, J Brillman, W Rothfus The Journal of Neuropsychiatry and Clinical Neurosciences 5 (3), 287-293, 1993 | 86 | 1993 |
| Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis EW Radue, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... Journal of the neurological sciences 292 (1-2), 28-35, 2010 | 84 | 2010 |
| Nosology of idiopathic transverse myelitis syndromes TF Scott Acta neurologica scandinavica 115 (6), 371-376, 2007 | 82 | 2007 |
| Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging TF Scott, D Hess, J Brillman Archives of internal medicine 154 (8), 917-920, 1994 | 72 | 1994 |
| Short-term prognosis in early relapsing-remitting multiple sclerosis TF Scott, CJ Schramke, J Novero, C Chieffe Neurology 55 (5), 689-693, 2000 | 71 | 2000 |
| Isolated neurosarcoidosis: case series in 2 sarcoidosis centers K Nozaki, TF Scott, M Sohn, MA Judson The neurologist 18 (6), 373-377, 2012 | 62 | 2012 |
| Characterization of major depression symptoms in multiple sclerosis patients. TF Scott, D Allen, TR Price, H McConnell, D Lang The Journal of Neuropsychiatry and Clinical Neurosciences 8 (3), 318-323, 1996 | 60 | 1996 |
| Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate RS Ramanathan, K Malhotra, T Scott BMC neurology 14, 1-5, 2014 | 59 | 2014 |
Christopher T HackettAHN Neuroscience InstituteAdresse e-mail validée de ahn.org
